Monovalent influenza A/H7N9 virus vaccine

BIOLOGICAL2 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID)

Conditions

Avian InfluenzaH1N1 InfluenzaInfluenza

Phase 2

H7N9 Boost in Healthy Adults

CompletedNCT02586792

National Institute of Allergy and Infectious Diseases (NIAID)Influenza

Start: 2016-01-12End: 2016-12-29Updated: 2018-08-22

H7N9 Vaccination With and Without AS03 and Unadjuvanted H3N2v Vaccination: Standard and Systems Biology Analyses

CompletedNCT02921997

National Institute of Allergy and Infectious Diseases (NIAID)Avian Influenza, H1N1 Influenza, Influenza

Start: 2016-11-07End: 2018-02-14Updated: 2024-10-09

Related Papers

Safety and immunogenicity of an 8 year interval heterologous prime-boost influenza A/H7N7-H7N9 vaccination.

2019-04-049 citations